CanSinoBIO | Briefing, News, Analysis, Research, Data

CanSinoBIO

CanSinoBIO ConSino Bio specializes in the development and production of high-qua

With a registered capital of RMB 156 million, ConSinoBio is a national high-tech enterprise founded by the senior management team of a multinational pharmaceutical company. With the mission of providing solutions for the prevention of infectious diseases and infectious diseases worldwide, ConSino Bio specializes in the development and production of high-quality human vaccines.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Jan 13, 2009

HQ location

Tianjin, China

Legal name

Tianjin Cansino Biotechnology Inc

Website

http://www.cansinotech.com

jian.xu@cansinotech.com

Employees

301-500

All
News
Analysis
Research

Briefing May 27, 2022 02:04 PM · Technology | Healthcare | Industrials

Hong Kong stock kangxinuo biological continued to rise, up more than 10% to HK $79.45.

Briefing May 20, 2022 09:45 AM · Technology | Healthcare | Financials

Business community: the fundamentals have improved, and PTA may remain upward

In-depth

Healthcare

Chinese Company Turned the Tables on Domestic Cell Culture Media Market

In this article, EqualOcean mainly introduce the history, competition, lead company, future trend in domestic cell culture media industry.

Feb 02, 2023 10:45 AM

Briefing May 19, 2022 10:34 PM · Healthcare | Financials

The new development bank issued 7 billion yuan of Panda Bonds for infrastructure projects in member countries

Briefing Apr 19, 2022 08:14 AM · Consumer Staples | Healthcare

361 degrees announced that the retail sales of main brand products in the first quarter recorded a high double-digit growth year-on-year.

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Healthcare, Financials, Technology

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Feb 25, 2022 06:58 PM · Technology | Healthcare | Automotive

Sun paper: the subsidiary plans to acquire 100% equity of Liujing Chengquan with 1.5 billion yuan

Briefing Feb 21, 2022 09:49 AM · Technology | Healthcare

The communication service sector opened stronger

Briefing Feb 20, 2022 03:49 PM · Healthcare

A fire broke out in a mechanical and electrical plant in Huaiyuan, Anhui Province, and local fire and public security departments are rescuing

Briefing Jan 31, 2022 10:29 AM · Healthcare

Hong Kong Pharmaceutical stocks generally rose, with Cinda biology up nearly 6%

Healthcare

HealthGuard: Registration of Indonesian Subsidiary, Investment in Producing HPV Vaccine

Jun 20, 2024 03:12 PM

Healthcare

SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year

EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.

Jun 06, 2024 06:18 PM

Briefing Jan 23, 2022 03:59 PM · Healthcare | Automotive

Great Wall Motor Performance express: in 2021, the net profit was 6.782 billion yuan, a year-on-year increase of 26.47%.

Briefing Jan 14, 2022 02:18 PM · Healthcare

Hong Kong stocks continued to rise in the anti epidemic sector, and Junshi biology rose nearly 17%

Briefing Dec 15, 2021 08:19 PM · Technology | Consumer Discretionary | Healthcare

The revised version of the detailed rules of the standards for the audit of network short video content was released

Healthcare

CNMPA Approved World's First Inhaled COVID-19 Vaccine Mist

The liquid form of the vaccine is changed into an aerosol using a nebulizer. It can then be inhaled through the mouth using the nebulizer machine. According to CanSino, the vaccine can effectively induce comprehensive immune protection in response to SARS-CoV-2 after just one breath.

Sep 06, 2022 11:48 AM

In the COVID-19 vaccine development competition, every participant is speeding up. Image credit: Jeremy Lapak / Unsplash

Healthcare · Analysis

China Speed: Two COVID-19 Vaccines Recognized by WHO

As the second blow of the pandemic comes near the sight, China's newly-developed vaccines have been approved by the World Health Organization and available at an affordable price.

Oct 02, 2020 10:30 PM

Briefing Dec 15, 2021 02:00 PM · Technology | Healthcare

Gem new shares continue to strengthen, and N Huayan is temporarily suspended

Briefing Dec 06, 2021 10:30 AM · Technology | Consumer Staples | Healthcare

Yuan universe concept stocks rose and warmed up, and shuobaid rose more than 8%

Briefing Dec 06, 2021 10:19 AM · Technology | Healthcare

Hong Kong Pharmaceutical stocks continued to decline, and Qiming medical fell more than 14%

Briefing Dec 05, 2021 04:19 PM · Consumer Staples | Financials | Automotive

Qin Lihong, President of Weilai: we will not launch flying cars, which is not on our reasonable strategic expansion route

EqualOcean Analysis